J. Mackay and G. Mensah, The atlas of heart disease and stroke, Geneva. World Health Organization, pp.84-91, 2004.

S. Yusuf, S. Hawken, S. Ounpuu, T. Dans, A. Avezum et al., Investigators IS, Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study, Lancet, vol.364, pp.937-52, 2004.

J. D. Haller and A. S. Olearchyk, Cardiology's 10 greatest discoveries, Tex. Heart Inst. J, vol.29, pp.342-346, 2002.

D. Choi, K. C. Hwang, K. Y. Lee, and Y. H. Kim, Ischemic heart diseases: Current treatments and future, Journal of Controlled Release, vol.140, pp.194-202, 2009.

A. Gruntzig, Trans-Luminal Dilatation of Coronary-Artery Stenosis, Lancet, vol.1, p.263, 1978.

U. Sigwart, J. Puel, V. Mirkovitch, F. Joffre, and L. Kappenberger, Intravascular Stents to Prevent Occlusion and Restenosis after Trans-Luminal Angioplasty, N. Engl. J. Med, vol.316, pp.701-707, 1987.

L. W. Klein and J. Rosenblum, Restenosis after Successful Percutaneous Transluminal Coronary Angioplasty, Prog. Cardiovasc. Dis, vol.32, pp.365-82, 1990.

J. H. Ip, V. Fuster, L. Badimon, J. Badimon, M. B. Taubman et al., Syndromes of Accelerated Atherosclerosis-Role of Vascular Injury and Smooth-Muscle CellProliferation, J. Am. Coll. Cardiol, vol.15, pp.1667-87, 1990.

B. J. Rensing, W. Hermans, K. J. Beatt, G. J. Laarman, H. Suryapranata et al., Quantitative Angiographic Assessment of Elastic Recoil after Percutaneous Transluminal Coronary Angioplasty, Am. J. Cardiol, vol.66, pp.1039-1083, 1990.

M. Nobuyoshi, T. Kimura, H. Nosaka, S. Mioka, K. Ueno et al., Restenosis after Successful Percutaneous Trans-Luminal Coronary Angioplasty-Serial Angiographic Follow-up of 229 Patients, J. Am. Coll. Cardiol, vol.12, pp.616-639, 1988.

H. Lowe, S. N. Oesterle, and L. M. Khachigian, Coronary in-stent restenosis:Current status and future strategies, J. Am. Coll. Cardiol, vol.39, pp.183-93, 2002.

D. L. Fischman, M. B. Leon, D. S. Baim, R. A. Schatz, M. P. Savage et al., A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary-Artery Disease, N. Engl. J. Med, vol.331, pp.496-501, 1994.

P. W. Serruys, P. Dejaegere, F. Kiemeneij, C. Macaya, W. Rutsch et al., A Comparison of BalloonExpandable-Stent Implantation with Balloon Angioplasty in Patients with CoronaryArtery Disease, N. Engl. J. Med, vol.331, pp.489-95, 1994.

R. Virmani and A. Farb, Pathology of in-stent restenosis, Curr. Opin. Lipidol, vol.10, pp.499-506, 1999.

M. Morice, P. W. Serruys, J. E. Sousa, J. Fajadet, E. B. Hayashi et al., A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization, N. Engl. J. Med, vol.346, pp.1773-80, 2002.

J. W. Moses, M. B. Leon, J. J. Popma, P. J. Fitzgerald, D. R. Holmes et al., Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery, N. Engl. J. Med, vol.349, pp.1315-1338, 2003.

E. Grube and L. Buellesfeld, Initial experience with paclitaxel-coated stents, J. Interv. Cardiol, vol.15, pp.471-476, 2002.

J. A. Spertus, R. Kettelkamp, C. Vance, C. Decker, P. G. Jones et al., Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement results from the PREMIER registry, Circulation, vol.113, pp.2803-2812, 2006.

A. Ong and P. W. Serruys, Symposium of the Texas-Heart-Institute on Current Issues in Cardiology, pp.372-379, 2005.

E. P. Mcfadden, E. Stabile, E. Regar, E. Cheneau, A. Ong et al., Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy, Lancet, vol.364, pp.1519-1540, 2004.

A. Ong, E. P. Mcfadden, E. Regar, P. De-jaegere, R. T. Van-domburg et al., Late angiographic stent thrombosis (LAST) events with drug-eluting stents, J. Am. Coll. Cardiol, vol.45, pp.2088-92, 2005.

P. K. Kuchulakanti, W. W. Chu, R. Torguson, P. Ohlmann, S. W. Rha et al., Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus-and paclitaxel-eluting stents, Circulation, vol.113, pp.1108-1121, 2006.

I. Iakovou, T. Schmidt, E. Bonizzoni, L. Ge, G. M. Sangiorgi et al., Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents, JAMA-J. Am. Med. Assoc, vol.293, pp.2126-2156, 2005.

, Boston scientific confirms long-term clotting risk of drug-eluting stents, Do drug-eluting stents increase deaths? , Retrieved September, 2006.

J. R. Nebeker, R. Virmani, C. L. Bennett, J. M. Hoffman, M. H. Samore et al., 54th Annual Scientific Session of the American-College-of-Cardiology, pp.175-81, 2005.

D. Stoeckel, C. Bonsignore, and S. Duda, A survey of stent designs, Minim. Invasive Ther. Allied Technol, vol.11, pp.137-184, 2002.

H. S. Borovetz, J. F. Burke, T. Chang, A. Colas, A. N. Cranin et al., , pp.455-707, 2004.

G. Mani, M. D. Feldman, D. Patel, and C. M. Agrawal, Coronary stents: A materials perspective, Biomaterials, vol.28, pp.1689-710, 2007.

R. A. Schatz, A view of vascular stents, Circulation, vol.79, pp.445-57, 1989.

J. Zahora, A. Bezrouk, and J. Hanus, Models of stents-Comparison and applications, Physiol. Res, vol.56, pp.115-136, 2007.

Y. P. Kathuria, The potential of biocompatible metallic stents and preventing restenosis, Materials Science and Engineering a-Structural Materials Properties Microstructure and Processing, vol.417, pp.40-48, 2006.

A. Konig, T. M. Schiele, J. Rieber, K. Theisen, H. Mudra et al., Stent design-related coronary artery remodeling and patterns of neointima formation following selfexpanding and balloon-expandable stent implantation, Catheter. Cardiovasc. Interv, vol.56, pp.478-86, 2002.

J. Park and J. Bronzino, Biomaterials: principles and applications, 2003.

B. Ratner, Biomaterials science: an introduction to materials in medicine, 2004.

B. Thierry, Y. Merhi, L. Bilodeau, C. Trepanier, and M. Tabrizian, Nitinol versus stainless steel stents: acute thrombogenicity study in an ex vivo porcine model, Biomaterials, vol.23, pp.2997-3005, 2002.

F. Cardarelli, Materials Handbook, pp.59-157, 2008.

S. A. Shabalovskaya, On the nature of the biocompatibility and on medical applications of NiTi shape memory and superelastic alloys, Biomed. Mater. Eng, vol.6, pp.267-89, 1996.

M. Bergergorbet, B. Broxup, C. Rivard, and L. H. Yahia, Biocompatibility testing of NiTi screws using immunohistochemistry on sections containing metallic implants, J. Biomed. Mater. Res, vol.32, pp.243-251, 1996.

M. F. Maitz and N. Shevchenko, Plasma-immersion ion-implanted nitinol surface with depressed nickel concentration for implants in blood, J. Biomed. Mater. Res. A, vol.76, pp.356-65, 2006.

O. 'brien, B. Carroll, W. M. Kelly, and M. J. , Passivation of nitinol wire for vascular implantsa demonstration of the benefits, Biomaterials, vol.23, pp.1739-1787, 2002.

C. Trepanier, M. Tabrizian, L. Yahia, L. Bilodeau, and D. L. Piron, Effect of modification of oxide layer on NiTi stent corrosion resistance, J. Biomed. Mater. Res, vol.43, pp.433-473, 1998.

M. M. Mazumder, S. De, S. Trigwell, N. Ali, M. K. Mazumder et al., Corrosion resistance of polyurethane-coated Nitinol cardiovascular stents, J. Biomater. Sci. Polym. Ed, vol.14, pp.1351-62, 2003.

D. Starosvetsky and I. Gotman, Corrosion behavior of titanium nitride coated Ni-Ti shape memory surgical alloy, Biomaterials, vol.22, pp.1853-1862, 2001.

C. C. Shih, S. J. Lin, K. H. Chung, Y. L. Chen, and Y. Y. Su, Increased corrosion resistance of stent materials by converting current surface film of polycrystalline oxide into amorphous oxide, J. Biomed. Mater. Res, vol.52, pp.323-355, 2000.

J. Butany, K. Carmichael, S. W. Leong, and M. J. Collins, Coronary artery stents: identification and evaluation, J. Clin. Pathol, vol.58, pp.795-804, 2005.

H. M. Burt and W. L. Hunter, Drug-eluting stents: A multidisciplinary success story, Adv. Drug Delivery Rev, vol.58, pp.350-357, 2006.

D. Mclean and N. Eiger, Stent design: implications for restenosis, Rev. Cardiovasc. Med, vol.3, p.16, 2002.

P. Gurbel, K. Callahan, A. Malinin, V. Serebruany, and J. Gillis, Could stent design affect platelet activation? Results of the Platelet Activation in STenting (PAST) Study, J. Invasive Cardiol, vol.14, pp.584-593, 2002.

A. Kastrati, J. Mehilli, J. Dirschinger, J. Pache, K. Ulm et al., Restenosis after coronary placement of various stent types, Am. J. Cardiol, vol.87, pp.34-43, 2001.

Y. Yoshitomi, S. Kojima, M. Yano, T. Sugi, Y. Matsumoto et al., Does stent design affect probability of restenosis? A randomized trial comparing Multilink stents with GFX stents, Am. Heart J, vol.142, pp.445-51, 2001.

C. Rogers and E. Edelman, Endovascular stent design dictates experimental restenosis and thrombosis, Circulation, vol.91, pp.2995-3001, 1995.

J. Hausleiter, A. Kastrati, J. Mehilli, H. Schuhlen, J. Pache et al., Imp-act of lesion complexity on the capacity of a trial to detect differences in stent performance: Results from the ISAR-STEREO trial, Am. Heart J, vol.146, pp.882-888, 2003.

K. Lau, J. A. Sigwart, U. Hung, and J. , A stent is not just a stent: stent construction and design do matter in its clinical performance, Singapore Med. J, vol.45, pp.305-317, 2004.

L. Thuesen, H. Andersen, L. Krusell, H. Botker, E. Jorgensen et al., Randomized comparison of the coil-design Crossflex and the tubular NIR stent, Catheter. Cardiovasc. Interv, vol.59, pp.8-12, 2003.

J. Pache, A. Kastrati, J. Mehilli, H. Schühlen, F. Dotzer et al., Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial, J. Am. Coll. Cardiol, vol.41, pp.1283-1291, 2003.

R. Hoffmann, G. S. Mintz, P. K. Haager, T. Bozoglu, E. Grube et al., Relation of stent design and stent surface material to subsequent in-stent intimal hyperplasia in coronary arteries determined by intravascular ultrasound, Am. J. Cardiol, vol.89, pp.1360-1364, 2002.

C. Briguori, C. Sarais, P. Pagnotta, F. Liistro, M. Montorfano et al., In-stent restenosis in small coronary arteries-Impact of strut thickness, J. Am. Coll. Cardiol, vol.40, pp.403-412, 2002.

A. Kastrati, J. Mehilli, J. Dirschinger, F. Dotzer, H. Schuhlen et al., Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome, vol.103, pp.2816-2837, 2001.

J. Pache, A. Dibra, J. Mehilli, J. Dirschinger, A. Schomig et al., Drug-eluting stents compared with thin-strut bare stents for the reduction of restenosis: a prospective, randomized trial, Eur. Heart J, vol.26, pp.1262-1270, 2005.

M. R. Bennett, In-stent stenosis: pathology and implications for the development of drug eluting stents, Heart, vol.89, pp.218-242, 2003.

G. Karthikeyan and B. Bhargava, Prevention of restenosis after coronary angioplasty, Curr. Opin. Cardiol, vol.19, pp.500-509, 2004.

Y. Rozenman, D. Gilon, S. Welber, D. Sapoznikov, and M. S. Gotsman, Clinical and Angiographic Predictors of Immediate Recoil after Successful Coronary Angioplasty and Relation to Late Restenosis, Am. J. Cardiol, vol.72, pp.1020-1025, 1993.

A. E. Rodriguez, I. F. Palacios, M. A. Fernandez, M. Larribau, M. Giraudo et al., Time-Course and Mechanism of Early Luminal Diameter Loss after Percutaneous Transluminal Coronary Angioplasty, Am. J. Cardiol, vol.76, pp.1131-1135, 1995.

C. White, Drug-Eluting Stents Advanced Applications for the Management of Coronary Disease, 2005.

M. W. Liu and . Rg, King SB III Restenosis following coronary angioplasty potential biological determinants and role of intimal hyperplasia, Circulation, vol.79, pp.1374-87, 1989.

R. Kornowski, M. K. Hong, F. O. Tio, O. Bramwell, H. S. Wu et al., In-stent restenosis: Contributions of inflammatory responses and arterial injury to neointimal hyperplasia, J. Am. Coll. Cardiol, vol.31, pp.224-254, 1998.

R. Komatsu, M. Ueda, T. Naruko, A. Kojima, and A. E. Becker, Neointimal tissue response at sites of coronary stenting in humans-Macroscopic, histological, and immunohistochemical analyses, Circulation, vol.98, pp.224-257, 1998.

I. Ott, F. J. Neumann, S. Kenngott, M. Gawaz, and A. Schomig, Procoagulant inflammatory responses of monocytes after direct balloon angioplasty in acute myocardial infarction, Am. J. Cardiol, vol.82, pp.938-980, 1998.

T. A. Smith-norowitz, J. Shani, W. Weiser, N. Schulhoff, K. Norowitz et al., Lymphocyte activation in angina pectoris, Clin. Immunol, vol.93, pp.168-75, 1999.

J. M. Breuss, M. Cejna, H. Bergmeister, A. Kadl, G. Baumgartl et al., Activation of nuclear factor-kappa B significantly contributes to lumen loss in a rabbit iliac artery balloon angioplasty model, Circulation, vol.105, pp.633-641, 2002.

P. Cirillo, P. Golino, M. Ragni, C. Battaglia, F. Pacifico et al., Activated platelets and leucocytes cooperatively stimulate smooth muscle cell proliferation and proto-oncogene expression via release of soluble growth factors, Cardiovasc. Res, vol.43, pp.210-218, 1999.

J. E. Rectenwald, L. L. Moldawer, T. S. Huber, J. M. Seeger, and C. K. Ozaki, Direct evidence for cytokine involvement in neointimal hyperplasia, Circulation, vol.102, pp.1697-702, 2000.

Y. Furukawa, A. Matsumori, N. Ohashi, T. Shioi, K. Ono et al., Anti-monocyte chemoattractant protein-1 monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteries, Circ. Res, vol.84, pp.306-320, 1999.

R. Schwartz and T. Henry, Pathophysiology of coronary artery restenosis, Rev. Cardiovasc. Med, vol.3, p.4, 2002.

A. M. Salam, A. Suwaidi, J. Holmes, and D. R. , Drug-eluting coronary stents, Curr. Probl. Cardiol, vol.31, pp.8-119, 2006.

A. W. Clowes and S. M. Schwartz, Significance of Quiescent Smooth-Muscle Migration in the Injured Rat Carotid-Artery, Circ. Res, vol.56, pp.139-184, 1985.

R. S. Schwartz and T. D. Henry, , p.4, 2002.

A. Wong and C. Chan, Drug-eluting stents: The end of restenosis? Ann, Acad. Med. Singap, vol.33, pp.423-454, 2004.

M. Joner, A. V. Finn, A. Farb, E. K. Mont, F. D. Kolodgie et al., Pathology of drug-eluting stents in humans-Delayed healing and late thrombotic risk, J. Am. Coll. Cardiol, vol.48, pp.193-202, 2006.

J. Daemen and P. W. Serruys, Drug-eluting stent update 2007 part I: a survey of current and future generation drug-eluting stents: meaningful advances or more of the same?, Circulation, vol.116, pp.316-344, 2007.

C. Unterberg, D. Sandrock, K. Nebendahl, and A. B. Buchwald, Reduced Acute Thrombus Formation Results in Decreased Neointimal Proliferation after Coronary Angioplasty, J. Am. Coll. Cardiol, vol.26, pp.1747-54, 1995.

R. S. Schwartz, D. J. Holder, D. R. Holmes, J. P. Veinot, A. R. Camrud et al., Neointimal thickening after severe coronary artery injury is limited by short-term administration of a factor Xa inhibitor-Results in a porcine model, Circulation, vol.93, pp.1542-1550, 1996.

A. Kastrati, H. Schuhlen, J. Hausleiter, H. Walter, E. Zitzmannroth et al., Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy-Six-month angiographic follow-up of the intracoronary stenting and antithrombotic regimen (ISAR) trial, Circulation, vol.96, pp.462-469, 1997.

S. Ellis, M. Effron, H. Gold, M. Leon, J. Popma et al., Acute platelet inhibition with abciximab does not reduce in-stent restenosis (ERASER study), Circulation, vol.100, pp.799-806, 1999.

E. Tsuchikane, A. Fukuhara, T. Kobayashi, M. Kirino, K. Yamasaki et al., Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty, Circulation, vol.100, pp.21-27, 1999.

C. W. Lee, J. K. Chae, H. Y. Lim, M. K. Hong, J. J. Kim et al., Prospective randomized trial of corticosteroids for the prevention of restenosis after intracoronary stent implantation, Am. Heart J, vol.138, pp.60-63, 1999.

T. Meurice, C. Bauters, X. Hermant, V. Codron, E. Vanbelle et al., Effect of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): a randomised, double-blind, placebo-controlled trial, Lancet, vol.357, pp.1321-1325, 2001.

P. Serruys, D. Foley, M. Pieper, J. Kleijne, T. The et al., A multicentre randomized placebo controlled clinical trial of trapidil for prevention of restenosis after coronary stenting, measured by 3-D intravascular ultrasound, Eur. Heart J, vol.22, 1938.

M. N. Babapulle and M. J. Eisenberg, Coated stents for the prevention of restenosis: Part I. Circulation, vol.106, pp.2734-2774, 2002.

V. A. Depalma, R. E. Baier, V. L. Gott, J. W. Ford, and A. Furuse, Investigation of 3-surface properties of several metals and their relation to blood compatibility, J. Biomed. Mater. Res, vol.6, pp.37-75, 1972.

J. F. Hecker and L. A. Scandrett, Roughness and Thrombogenecity of the outer surfaces of intravascular catheters, J. Biomed. Mater. Res, vol.19, pp.381-95, 1985.

S. Trigwell, R. D. Hayden, K. F. Nelson, and G. Selvaduray, Effects of surface treatment on the surface chemistry of NiTi alloy for biomedical applications, vol.26, pp.483-492, 1998.

N. Eliaz and O. Nissan, Innovative processes for electropolishing of medical devices made of stainless steels, J. Biomed. Mater. Res. A, vol.83, pp.546-57, 2007.

G. William and A. Wood, ASM Surface Treating and Coating Division Council, p.715, 1982.

M. Haidopoulos, S. Turgeon, C. Sarra-bournet, G. Laroche, and D. Mantovani, Development of an optimized electrochemical process for subsequent coating of 316 stainless steel for stent applications, J. Mater. Sci. Mater. Med, vol.17, pp.647-57, 2006.

H. Zhao, V. Humbeeck, J. Sohier, J. , D. Scheerder et al., Electrochemical polishing of 316L stainless steel slotted tube coronary stents, J. Mater. Sci. Mater. Med, vol.13, pp.911-917, 2002.

A. Raval, A. Choubey, C. Engineer, and D. Kothwala, Development and assessment of 316LVM cardiovascular stents, Materials Science and Engineering a-Structural Materials Properties Microstructure and Processing, vol.386, pp.331-374, 2004.

K. Wang, Biocompatibilisation of coronary artery stents, 1997.

S. Sheth, . Lf, M. C. Fishbein, J. S. Forrester, and N. L. Eigler, Reduced thrombogenicity of polished and unpolished nitinol vs. stainless steel slotted-tube stents in a pig coronary artery model, JACC, 1996.

D. Scheerder, I. Verbeken, E. Van-humbeeck, J. , and S. , , pp.139-183, 1998.

D. Scheerder, I. Sohier, J. Verbeken, E. Froyen, L. Van-humbeeck et al., Biocompatibility of coronary stent materials: Effect of electrochemical polishing, Materialwissenschaft Und Werkstofftechnik, vol.32, pp.142-150, 2001.

D. Scheerder, I. Wang, K. Sohier, J. Verbeken, E. Zhou et al., Metallic surface treatment using electrochemical polishing decreases thrombogenicity and neointimal hyperplasia after coronary stent implantation in a porcine model, J. Am. Coll. Cardiol, vol.31, p.277, 1998.

C. Hehrlein, M. Zimmermann, J. Metz, W. Ensinger, and W. Kubler, Influence of Surface Texture and Charge on the Biocompatibility of Endovascular Stents, Coron. Artery Dis, vol.6, pp.581-587, 1995.

C. L. Liu, P. K. Chu, G. Q. Lin, and M. Qi, Anti-corrosion characteristics of nitride-coated AISI 316L stainless steel coronary stents, Surface & Coatings Technology, vol.201, pp.2802-2808, 2006.

A. W. Heldman, L. Cheng, G. M. Jenkins, P. F. Heller, D. W. Kim et al., Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis, Circulation, vol.103, pp.2289-95, 2001.

M. C. Chen, H. F. Liang, Y. L. Chiu, Y. Chang, H. J. Wei et al., A novel drug-eluting stent spray-coated with multi-layers of collagen and sirolimus, J. Control. Release, vol.108, pp.178-89, 2005.

N. Huang, Y. Leng, P. Yang, J. Chen, H. Sun et al., Surface modification of coronary artery stent by Ti-O/Ti-N complex film coating prepared with plasma immersion ion implantation and deposition, Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms, vol.242, pp.18-21, 2006.

K. Nguyen, S. Su, M. Zilberman, P. Bohluli, P. Frenkel et al., Biomaterials and stent technology. Tissue engineering and novel delivery systems, p.107, 2004.

H. Hara, M. Nakamura, J. C. Palmaz, and R. S. Schwartz, Role of stent design and coatings on restenosis and thrombosis, Adv. Drug Delivery Rev, vol.58, pp.377-86, 2006.

S. H. Duda, T. C. Poerner, B. Wiesinger, J. H. Rundback, G. Tepe et al., Drug-eluting stents: Potential applications for peripheral arterial occlusive disease, J. Vasc. Interv. Radiol, vol.14, pp.291-301, 2003.

E. Edelman, P. Seifert, A. Groothuis, A. Morss, D. Bornstein et al., Gold-coated NIR stents in porcine coronary arteries, Circulation, vol.103, pp.429-463, 2001.

S. Harding, C. Mckenna, A. Flapan, and N. Boon, Long-term clinical safety and efficacy of NIROYAL vs. NIR intracoronary stent, Cathet. Cardiovasc. Diagn, vol.54, pp.141-146, 2001.

A. Cremonesi, E. Benit, M. Carlier, A. Colombo, R. Piva et al., Multicenter registry to evaluate the efficacy of the NIROYAL? Stent in de novo or restenotic coronary stenosis, J. Invasive Cardiol, vol.12, pp.225-260, 2000.

A. Kastrati, A. Schomig, J. Dirschinger, J. Mehilli, V. Welser et al., Increased risk of restenosis after placement of gold-coated stents: results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease, Circulation, vol.101, p.2478, 2000.

S. Hofma, H. Van-beusekom, P. Serruys, and W. Van-der-giessen, Recent Developments in Coated Stents. Current interventional cardiology reports, vol.3, p.28, 2001.

J. Dahl, P. Haager, E. Grube, M. Gross, C. Beythien et al., Effects of gold coating of coronary stents on neointimal proliferation following stent implantation* 1, Am. J. Cardiol, vol.89, pp.801-806, 2002.

G. Danzi, C. Capuano, M. Sesana, D. Blasi, A. Predolini et al., Patterns of instent restenosis after placement of NIR gold-coated stents in unselected patients, Catheter. Cardiovasc. Interv, vol.55, pp.157-62, 2002.

S. Monnink, A. Van-boven, H. Peels, I. Tigchelaar, D. Kam et al., Silicon-carbide coated coronary stents have low platelet and leukocyte adhesion during platelet activation, Clinical Research, vol.47, pp.304-314, 1999.

A. Bolz and M. Schaldach, Artificial-Heart Valves-Improved Blood Compatibility by Pecvd a-Sic-H Coating, Artif. Organs, vol.14, pp.260-269, 1990.

C. Harder, A. Rzany, and M. Schaldach, Coating of vascular stents with antithrombogenic amorphous silicon carbide, Prog Biomed Res, vol.4, pp.71-78, 1999.

B. Heublein, K. Pethig, and A. Elsayed, Silicon Carbide Coating-A Semiconducting Hybrid Design of Coronary Stents-A Feasibility Study, J. Invasive Cardiol, vol.10, pp.255-62, 1998.

U. Kalnins, A. Erglis, I. Dinne, I. Kumsars, and S. Jegere, Clinical outcomes of silicon carbide coated stents in patients with coronary artery disease, Medical science monitor: international medical journal of experimental and clinical research, vol.8, pp.16-20, 2002.

M. Unverdorben, B. Sippel, R. Degenhardt, K. Sattler, R. Fries et al., Comparison of a silicon carbide-coated stent versus a noncoated stent in human beings: The Tenax versus Nir Stent Study's longterm outcome, Am. Heart J, vol.145, p.17, 2003.

L. Tanajura, A. Abizaid, F. Feres, I. Pinto, L. Mattos et al., Randomized intravascular ultrasound comparison between patients that underwent amorphous hydrogenated Silicon-Carbide coated stent deployment versus uncoated stents (abstr
DOI : 10.1016/s0735-1097(03)80247-4

URL : https://doi.org/10.1016/s0735-1097(03)80247-4

, J. Am. Coll. Cardiol, vol.41, p.58, 2003.

K. Gutensohn, C. Beythien, J. Bau, T. Fenner, P. Grewe et al., In vitro analyses of diamond-like carbon coated stents: Reduction of metal ion release, platelet activation, and thrombogenicity, Thromb. Res, vol.99, pp.577-85, 2000.

F. Airoldi, A. Colombo, D. Tavano, G. Stankovic, S. Klugmann et al., Comparison of diamond-like carbon-coated stents versus uncoated stainless steel stents in coronary artery disease, Am. J. Cardiol, vol.93, pp.474-481, 2004.

D. Antoniucci, R. Valenti, A. Migliorini, G. Moschi, M. Trapani et al., Clinical and angiographic outcomes following elective implantation of the Carbostent in patients at high risk of restenosis and target vessel failure, Cathet. Cardiovasc. Diagn, vol.54, pp.420-426, 2001.

A. Colombo, F. Airoldi, and P. Coating, The Dream Does Not Come True, J Invas Cardiol, vol.15, pp.566-573, 2003.

C. Seliger, R. Mccall, W. P. Wolf, A. Resch, and E. U. Alt, Influence of a rough, ceramic-like stent surface made of iridium oxide on neointimal structure and thickening in an animal study: 1 and 6 month data, Circulation, vol.102, p.733, 2000.

D. Mario, C. Grube, E. Nisanci, Y. Reifart, N. Colombo et al., MOONLIGHT: a controlled registry of an iridium oxide-coated stent with angiographic follow-up, Int. J. Cardiol, vol.95, pp.329-360, 2004.

S. Windecker, I. Mayer, D. Pasquale, G. Maier, W. Dirsch et al., Working Grp Novel Surface C, Stent coating with titanium-nitride-oxide for reduction of neointimal hyperplasia, Circulation, vol.104, pp.928-961, 2001.

S. Windecker, R. D. Simon, M. Lins, V. Klauss, F. R. Eberli et al., Randomized comparison of a titanium-nitride-oxide coated stent with a stainless steel Stent for coronary revascularization, Circulation, vol.111, pp.2617-2639, 2005.

P. Karjalainen, A. Ylitalo, M. Niemelä, K. Kervinen, T. Mäkikallio et al., Two-year follow-up after percutaneous coronary intervention with titanium-nitride-oxide-coated stents versus paclitaxeleluting stents in acute myocardial infarction, Annals of medicine, vol.41, pp.599-607, 2009.

P. P. Karjalainen, A. P. Annala, A. Ylitalo, T. Vahlberg, and K. Airaksinen, Long-term clinical outcome with titanium-nitride-oxide-coated stents and paclitaxel-eluting stents for coronary revascularization in an unselected population, Int. J. Cardiol, vol.144, pp.42-48, 2010.

A. Kraitzer, Y. Kloog, and M. Zilberman, Approaches for prevention of restenosis, J. Biomed. Mater. Res. B Appl. Biomater, vol.85, pp.583-603, 2008.

W. Van-der-giessen, A. Lincoff, R. Schwartz, H. Van-beusekom, P. Serruys et al., Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries, Circulation, vol.94, pp.1690-1697, 1996.

A. Shikanov, B. Vaisman, M. Y. Krasko, A. Nyska, and A. J. Domb, Poly(sebacic acid-coricinoleic acid) biodegradable carrier for paclitaxel: In vitro release and in vivo toxicity, J. Biomed. Mater. Res. A, vol.69, pp.47-54, 2004.

S. H. Lee, I. Szinai, K. Carpenter, R. Katsarava, G. Jokhadze et al., Coron. Artery Dis, vol.13, pp.237-278, 2002.

E. Grenadier, A. Roguin, I. Hertz, B. Peled, M. Boulos et al., Stenting very small coronary narrowings (< 2 mm) using the biocompatible phosphorylcholine-coated coronary stent, Catheter. Cardiovasc. Interv, vol.55, pp.303-311, 2002.

M. Galli, A. Bartorelli, F. Bedogni, N. Decesare, S. Klugmann et al., Italian BiodivYsio open registry (BiodivYsio PC-coated stent): Study of clinical outcomes of the implant of a PC-coated coronary stent, J. Invasive Cardiol, vol.12, pp.452-460, 2000.

H. Zheng, P. Barragan, T. Corcos, J. Simeoni, X. Favereau et al., Clinical experience with a new biocompatible phosphorylcholine-coated coronary stent, J Invasive Cardiol, vol.11, pp.608-622, 1999.

J. Moses, C. Buller, E. Nukta, A. Aluka, G. Barbeau et al., The first clinical trial comparing a coated versus a non-coated coronary stent: The Biocompatibles BiodivYsio? stent in randomised control trial (distinct), Circulation, vol.102, p.11664, 2000.

S. Verheye, C. P. Markou, M. Y. Salame, B. Wan, S. B. King et al., Reduced thrombus formation by hyaluronic acid coating of endovascular devices, Atherioscler Thromb Vasc Biol, vol.20, pp.1168-72, 2000.
DOI : 10.1161/01.atv.20.4.1168

URL : http://atvb.ahajournals.org/content/atvbaha/20/4/1168.full.pdf

M. Radosevich, H. A. Goubran, and T. Burnouf, Fibrin sealant: Scientific rationale, production methods, properties, and current clinical use. Vox Sang, vol.72, pp.133-176, 1997.
DOI : 10.1046/j.1423-0410.1997.7230133.x

D. R. Holmes, A. R. Camrud, M. A. Jorgenson, W. D. Edwards, and R. S. Schwartz, Polymeric Stenting in the Porcine Coronary-Artery Model-Differential Outcome of Exogenous Fibrin Sleeves Versus Polyurethane-Coated Stents, J. Am. Coll. Cardiol, vol.24, pp.525-556, 1994.

C. J. Mckenna, A. R. Camrud, G. Sangiorgi, H. M. Kwon, W. D. Edwards et al., Fibrin-film stenting in a porcine coronary injury model: Efficacy and safety compared with uncoated stents, J. Am. Coll. Cardiol, vol.31, pp.1434-1442, 1998.

A. Byer, S. Peters, F. Settepani, M. Pagliaro, and G. Galletti, Fibrin sealant coated stents compared with non-coated stents in a porcine carotid artery model-Preliminary study report, J. Cardiovasc. Surg. (Torino), vol.42, pp.543-552, 2001.

I. Descheerder, K. Wang, K. Wilczek, D. Meuleman, R. Vanamsterdam et al., Experimental study of thrombogenicity and foreign body reaction induced by heparin-coated coronary stents, Circulation, vol.95, pp.1549-53, 1997.

P. A. Hardhammar, H. Vanbeusekom, H. U. Emanuelsson, S. H. Hofma, P. A. Albertsson et al., Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries, Circulation, vol.93, pp.423-453, 1996.

Y. K. Ahn, M. H. Jeong, J. W. Kim, S. H. Kim, J. H. Cho et al., Preventive effects of the heparin-coated stent on restenosis in the porcine model, Catheter. Cardiovasc. Interv, vol.48, pp.324-354, 1999.

Y. Matsumoto, H. Shimokawa, K. Morishige, Y. Eto, and A. Takeshita, Reduction in neointimal formation with a stent coated with multiple layers of releasable heparin in porcine coronary arteries, J. Cardiovasc. Pharmacol, vol.39, pp.513-535, 2002.

E. Semiz, C. Ermis, S. Yalçinkaya, O. Sancaktar, and N. Deger, Comparison of initial efficacy and long-term follow-up of heparin-coated Jostent with conventional NIR stent, Jpn. Heart J, vol.44, pp.889-98, 2003.

M. Haude, T. Konorza, U. Kalnins, A. Erglis, K. Saunamaki et al., Heparin-coated stent placement for the treatment of stenoses in small coronary arteries of symptomatic patients, Circulation, vol.107, pp.1265-70, 2003.

J. Wohrle, E. Al-khayer, U. Grotzinger, C. Schindler, M. Kochs et al., Comparison of the heparin coated vs the uncoated Jostent (R)-no influence on restenosis or clinical outcome, Eur. Heart J, vol.22, pp.1808-1824, 2001.

L. Pendyala, R. Jabara, T. Shinke, N. Chronos, K. Robinson et al., Drug-Eluting Stents: Present and Future, Cardiovasc. Hematol. Agents Med. Chem, vol.6, pp.105-120, 2008.

K. Nguyen, S. H. Su, M. Zilberman, P. Bohluli, P. Frenkel et al., Tissue engineering and novel delivery systems, p.107, 2004.

R. Virmani, G. Guagliumi, A. Farb, G. Musumeci, N. Grieco et al., Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent should we be cautious? Circulation, vol.109, pp.701-706, 2004.
DOI : 10.1161/01.cir.0000116202.41966.d4

URL : http://circ.ahajournals.org/content/circulationaha/109/6/701.full.pdf

R. Virmani, A. Farb, G. Guagliumi, and F. D. Kolodgie, Drug-eluting stents: caution and concerns for long-term outcome, Coron. Artery Dis, vol.15, pp.313-321, 2004.
DOI : 10.1097/00019501-200409000-00003

R. Virmani, F. Kolodgie, and A. Farb, Drug-eluting stents: Are they really safe?, Am. Heart Hosp. J, vol.2, pp.85-93, 2004.
DOI : 10.1111/j.1541-9215.2004.03632.x

A. V. Finn, G. Nakazawa, M. Joner, F. D. Kolodgie, E. K. Mont et al., Vascular responses to drug eluting stents, Arterioscler. Thromb. Vasc. Biol, vol.27, pp.1500-1510, 2007.

R. W. Harper, Drug-eluting coronary stents-a note of caution, Med. J. Aust, vol.186, pp.253-258, 2007.

H. Wieneke, O. Dirsch, T. Sawitowski, Y. L. Gu, H. Brauer et al., Synergistic effects of a novel nanoporous stent coating and tacrolimus on intima proliferation in rabbits, Catheter. Cardiovasc. Interv, vol.60, pp.399-407, 2003.

M. Kollum, A. Farb, R. Schreiber, K. Terfera, A. Arab et al., Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis, Catheter. Cardiovasc. Interv, vol.64, pp.85-90, 2005.

I. Tsujino, J. Ako, Y. Honda, and P. J. Fitzgerald, Drug delivery via nano-, micro and macroporous coronary stent surfaces, Expert Opin. Drug Deliv, vol.4, pp.287-95, 2007.

H. Kang, D. Kim, S. Park, J. Yoo, and Y. Ryu, Controlled drug release using nanoporous anodic aluminum oxide on stent. Thin solid films, vol.515, pp.5184-5191, 2007.

A. Rajtar, Y. Q. Kg, D. Hakimi, D. Liu, M. Tsui et al., Hydroxyapatite-coated cardiovascular stents, vol.2, pp.113-118, 2006.

J. R. Costa, A. Abizaid, R. Costa, F. Feres, L. F. Tanajura et al., Preliminary Results of the Hydroxyapatite Nonpolymer-Based Sirolimus-Eluting Stent for the Treatment of Single De Novo Coronary Lesions A First-in-Human Analysis of a Third-Generation Drug-Eluting Stent System, Jacc-Cardiovascular Interventions, vol.1, pp.545-51, 2008.

R. Wessely, J. Hausleiter, C. Michaelis, B. Jaschke, M. Vogeser et al., Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating, Arterioscler. Thromb. Vasc. Biol, vol.25, pp.748-53, 2005.

J. Mehilli, A. Kastrati, R. Wessely, A. Dibra, J. Hausleiter et al., Randomized trial of a nonpolymer-based rapamycin-eluting stent versus a polymer-based paclitaxel-eluting stent for the reduction of late lumen loss, Circulation, vol.113, pp.273-282, 2006.

B. Bhargava, N. K. Reddy, G. Karthikeyan, R. Raju, S. Mishra et al., A novel paclitaxel eluting porous carbon-carbon nanoparticle coated, nonpolymeric cobalt-chromium stent: Evaluation in a porcine model, Catheter. Cardiovasc. Interv, vol.67, pp.698-702, 2006.

M. Morice, H. Bestehorn, C. D. Macaya, C. Aengevareen, W. Wijns et al., Direct stenting of de novo coronary stenoses with tacrolimus-eluting versus carbon-coated carbostents. The randomized JUPITER II trial, EuroIntervention, vol.2, pp.45-52, 2006.

A. Lansky, R. Costa, G. Mintz, Y. Tsuchiya, M. Midei et al., Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow-up of the DELIVER clinical trial, Circulation, vol.109, pp.1948-54, 2004.

J. F. Granada, S. Inami, M. S. Aboodi, A. Tellez, K. Milewski et al., Development of a Novel Prohealing Stent Designed to Deliver Sirolimus From a Biodegradable Abluminal Matrix, Cir Cardiovas Interv, vol.3, pp.257-66, 2010.

J. Spinke, M. Liley, H. Guder, L. Angermaier, and W. Knoll, Molecular recognition at selfassembled monolayers: the construction of multicomponent multilayers, Langmuir, vol.9, pp.1821-1826, 1993.

G. Sigal, C. Bamdad, A. Barberis, J. Strominger, and G. Whitesides, A self-assembled monolayer for the binding and study of histidine-tagged proteins by surface plasmon resonance, Anal. Chem, vol.68, pp.490-497, 1996.

K. Fujita, N. Bunjes, K. Nakajima, M. Hara, H. Sasabe et al., Macrodipole interaction of helical peptides in a self-assembled monolayer on gold substrate, Langmuir, vol.14, pp.6167-72, 1998.

B. Houseman, E. Gawalt, and M. Mrksich, Maleimide-Functionalized Self-Assembled Monolayers for the Preparation of Peptide and Carbohydrate Biochips ?, Langmuir, vol.19, pp.1522-1553, 2003.

E. Huang and F. Zhou, Studies of surface coverage and orientation of DNA molecules immobilized onto preformed alkanethiol self-assembled monolayers, Langmuir, vol.16, pp.3272-80, 2000.

M. Riepl, K. Enander, B. Liedberg, M. Schäferling, M. Kruschina et al., Functionalized surfaces of mixed alkanethiols on gold as a platform for oligonucleotide microarrays, Langmuir, vol.18, pp.7016-7039, 2002.

S. Herrwerth, T. Rosendahl, C. Feng, J. Fick, W. Eck et al., Covalent Coupling of Antibodies to Self-Assembled Monolayers of CarboxyFunctionalized Poly (ethylene glycol): Protein Resistance and Specific Binding of Biomolecules ?, Langmuir, vol.19, pp.1880-1887, 2003.

Y. Kwon, Z. Han, E. Karatan, M. Mrksich, and B. Kay, Antibody arrays prepared by cutinase-mediated immobilization on self-assembled monolayers, Anal. Chem, vol.76, pp.5713-5733, 2004.

E. Gawalt, M. Avaltroni, M. Danahy, B. Silverman, E. Hanson et al., Bonding organics to Ti alloys: facilitating human osteoblast attachment and spreading on surgical implant materials, Langmuir, vol.19, pp.200-204, 2003.

N. Adden, L. Gamble, D. Castner, A. Hoffmann, G. Gross et al., Phosphonic acid monolayers for binding of bioactive molecules to titanium surfaces, Langmuir, vol.22, pp.8197-204, 2006.

A. Mahapatro, D. Johnson, D. Patel, M. Feldman, A. Ayon et al., Surface modification of functional self-assembled monolayers on 316L stainless steel via lipase catalysis, Langmuir, vol.22, pp.901-906, 2006.

A. Mahapatro, D. Johnson, D. Patel, M. Feldman, A. Ayon et al., Drug delivery from therapeutic self-assembled monolayers (T-SAMs) on 316L stainless steel, Curr Top Med Chem, vol.8, pp.281-290, 2008.

G. Mani, D. Johnson, D. Marton, M. Feldman, D. Patel et al., Drug delivery from gold and titanium surfaces using self-assembled monolayers, Biomaterials, vol.29, pp.4561-73, 2008.

C. Tidwell, S. Ertel, B. Ratner, B. Tarasevich, S. Atre et al., Endothelial cell growth and protein adsorption on terminally functionalized, self-assembled monolayers of alkanethiolates on gold, Langmuir, vol.13, pp.3404-3417, 1997.

A. Ulman, Formation and structure of self-assembled monolayers, Chem. Rev, vol.96, pp.1533-54, 1996.

J. Love, L. Estroff, J. Kriebel, R. Nuzzo, and G. Whitesides, Self-assembled monolayers of thiolates on metals as a form of nanotechnology, Chem. Rev, vol.105, pp.1103-70, 2005.

E. Gawalt, M. Avaltroni, N. Koch, and J. Schwartz, Self-assembly and bonding of alkanephosphonic acids on the native oxide surface of titanium, Langmuir, vol.17, pp.5736-5744, 2001.

R. Helmy and A. Fadeev, C18H37Si (CH3) 2Cl, and C18H37PO (OH) 2. Langmuir, Self-assembled monolayers supported on TiO2: comparison of C18H37SiX3 (X= H, Cl, OCH3), vol.18, pp.8924-8932, 2002.

R. Hofer, M. Textor, and N. Spencer, Alkyl phosphate monolayers, self-assembled from aqueous solution onto metal oxide surfaces, Langmuir, vol.17, pp.4014-4034, 2001.

S. Tosatti, R. Michel, M. Textor, and N. Spencer, Self-assembled monolayers of dodecyl and hydroxy-dodecyl phosphates on both smooth and rough titanium and titanium oxide surfaces, Langmuir, vol.18, pp.3537-3585, 2002.

M. Zwahlen, S. Tosatti, M. Textor, and G. Hähner, Orientation in methyl-and hydroxylterminated self-assembled alkanephosphate monolayers on titanium oxide surfaces investigated with soft X-ray absorption, Langmuir, vol.18, pp.3957-62, 2002.

B. Silverman, K. Wieghaus, and J. Schwartz, Comparative properties of siloxane vs phosphonate monolayers on a key titanium alloy, Langmuir, vol.21, pp.225-233, 2005.

S. Clair, F. Variola, M. Kondratenko, P. Jedrzejowski, A. Nanci et al., Self-assembled monolayer of alkanephosphoric acid on nanotextured Ti, J Chem Phys, vol.128, p.144705, 2008.
URL : https://hal.archives-ouvertes.fr/hal-01896178

A. Raman, M. Dubey, I. Gouzman, and E. Gawalt, Formation of self-assembled monolayers of alkylphosphonic acid on the native oxide surface of SS316L, Langmuir, vol.22, pp.6469-72, 2006.

C. Kang and Y. Lee, The surface modification of stainless steel and the correlation between the surface properties and protein adsorption, J Mater Sci-Mater Med, vol.18, pp.1389-98, 2007.

D. Puleo, Biochemical surface modification of Co-Cr-Mo, Biomaterials, vol.17, pp.217-239, 1996.

R. Quiñones and E. Gawalt, Study of the formation of self-assembled monolayers on nitinol, Langmuir, vol.23, pp.10123-10153, 2007.

G. Zorn, R. Adadi, R. Brener, V. Yakovlev, I. Gotman et al., Tailoring the Surface of NiTi Alloy Using PIRAC Nitriding Followed by Anodization and Phosphonate Monolayer Deposition, Chem. Mater, vol.20, pp.5368-74, 2008.

D. Palma, R. Laureyn, W. Frederix, F. Bonroy, K. Pireaux et al., Formation of dense self-assembled monolayers of (n-decyl) trichlorosilanes on Ta/Ta2O5, Langmuir, vol.23, pp.443-51, 2007.

M. Textor, L. Ruiz, R. Hofer, A. Rossi, K. Feldman et al., Structural chemistry of self-assembled monolayers of octadecylphosphoric acid on tantalum oxide surfaces, Langmuir, vol.16, pp.3257-71, 2000.

M. Chorny, I. Fishbein, B. Yellen, I. Alferiev, M. Bakay et al., Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields, Proceedings of the National Academy of Sciences, vol.107, pp.8346-51, 2010.

B. Polyak, I. Fishbein, M. Chorny, I. Alferiev, D. Williams et al., High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steed stents, Proc. Natl. Acad. Sci. U. S. A, vol.105, pp.698-703, 2008.

J. J. Wykrzykowska, Y. Onuma, and P. W. Serruys, Advances in stent drug delivery: the future is in bioabsorbable stents, Expert Opin. Drug Deliv, vol.6, pp.113-139, 2009.

J. Ormiston, P. Serruys, C. Bioabsorbable, and . Stents, Cir Cardiovasc Interv, vol.2, pp.255-60, 2009.

T. Tsuji,

H. Tamai,

K. Igaki, Y. Kosuga, K. Hata, T. Okada, M. Nakamura et al., Four-year follow-up of the biodegradable stent (Igaki-Tamai stent), Circ. J, vol.68, p.135, 2004.

F. Vogt, A. Stein, G. Rettemeier, N. Krott, R. Hoffmann et al., Long-term assessment of a novel biodegradable paclitaxel-eluting coronary polylactide stent, Eur. Heart J, vol.25, pp.1330-1370, 2004.

T. Okamura, S. Garg, J. L. Gutierrez-chico, E. Shin, Y. Onuma et al., In vivo evaluation of stent strut distribution patterns in the bioabsorbable everolimus-eluting device: an OCT ad hoc analysis of the revision 1.0 and revision 1.1 stent design in the ABSORB clinical trial, EuroIntervention, vol.5, pp.932-940, 2010.

P. W. Serruys, B: device design, 6-month update, and first report of the 12month results, Proceedings of TCT, 2010.

. Washington,

J. A. Ormiston, P. W. Serruys, E. Regar, D. Dudek, L. Thuesen et al., A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial, The Lancet, vol.371, pp.899-907, 2008.

P. W. Serruys, J. A. Ormiston, Y. Onuma, E. Regar, G. N. Garcia-garcia et al., A bioabsorbable everolimuseluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods, The Lancet, vol.373, pp.897-910, 2009.

E. Grube, The REVA tyrosine-derived polycarbonate bioabsorbable stent: final results from the RESORB first-in-man clinical trial and next generation designs. Proceedings of TCT, 2008.

. Washington,

M. J. Pollman, Engineering a bioresorbable stent: REVA programme update, EuroIntervention, vol.5, pp.54-61, 2009.

A. Abizaid, The REVA tyrosine-derived polycarbonate bioabsorbable stent: lessons learned and future directions, 2009.

S. Francisco,

R. Jabara, L. Pendyala, S. Geva, J. Chen, N. Chronos et al., Novel fully bioabsorbale salicylate-based sirolimuseluting stent, EuroIntervention, vol.5, pp.58-64, 2009.

A. Abizaid, The BTI salycilate-based polyanhydride ester absorbable sirolimus-eluting stent: update from the Whisper study, Proceedings of TCT, 2008.

. Washington,

R. Jabara, Poly-anhydride based on salicylic acid and adipic acid anhydride, Proceedings of Euro PCR, 2009.

H. Hermawan, D. Dube, and D. Mantovani, Developments in metallic biodegradable stents, Acta Biomater, vol.6, pp.1693-1700, 2010.

R. Erbel, D. Mario, C. Bartunek, J. Bonnier, J. De-bruyne et al., Investigators P-A, Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial, Lancet, vol.369, pp.1869-75, 2007.

R. Waksman, Current state of the absorbable metallic (magnesium)stent, EuroIntervention, vol.5, pp.94-102, 2009.

N. Kipshidze, G. Dangas, M. Tsapenko, J. Moses, M. B. Leon et al., Role of the endothelium in modulating neointimal formation-Vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions, J. Am. Coll. Cardiol, vol.44, pp.733-742, 2004.

P. M. Consigny, Endothelial cell seeding on prosthetic surfaces, J. Long. Term Eff. Med. Implants, vol.10, pp.79-95, 2000.

S. R. Bailey, . Dy, and E. Sprague, Endothelial seeding: intraprocedural replacement of endothelial cells on endovascular stents, Circulation, vol.94, 1997.

T. Shirota, H. Yasui, H. Shimokawa, and T. Matsuda, Fabrication of endothelial progenitor cell (EPC)-seeded intravascular stent devices and in vitro endothelialization on hybrid vascular tissue, Biomaterials, vol.24, pp.2295-302, 2003.

J. Aoki, P. W. Serruys, H. Van-beusekom, A. Ong, E. P. Mcfadden et al., Endothelial progenitor cell capture by stents coated with antibody against CD34-The HEALINGFIM (healthy endothelial accelerated lining inhibits neointimal growth-first in man) registry, J. Am. Coll. Cardiol, vol.45, pp.1574-1583, 2005.

E. Van-belle, F. Tio, T. Couffinhal, L. Maillard, J. Passeri et al., Stent endothelialization: time course, impact of local catheter delivery, feasibility of recombinant protein administration, and response to cytokine expedition, Circulation, vol.95, pp.438-486, 1997.

E. Van-belle, F. Tio, D. Chen, L. Maillard, M. Kearney et al., Passivation of metallic stents after arterial gene transfer of phVEGF165 inhibits thrombus formation and intimal thickening, J. Am. Coll. Cardiol, vol.29, pp.1371-1380, 1997.

E. Shantsila, T. Watson, and G. Lip, Endothelial progenitor cells in cardiovascular disorders, J. Am. Coll. Cardiol, vol.49, pp.741-52, 2007.

J. F. Tanguay, 58th Annual Meeting of the Canadian-Cardiovascular-Society, pp.1025-1055, 2005.

R. R. Anis and K. R. Karsch, The future of drug eluting stents, Heart, vol.92, pp.585-593, 2006.

H. J. Cho, T. Y. Kim, H. J. Cho, K. W. Park, S. Y. Zhang et al., The effect of stem cell mobilization by granulocyte-colony stimulating factor on neointimal hyperplasia and endothelial healing after vascular injury with bare-metal versus paclitaxel-eluting stents, J. Am. Coll. Cardiol, vol.48, pp.366-74, 2006.

J. Pelisek, A. T. Fuchs, A. Kuehnl, W. Tian, M. T. Kuhlmann et al., Type natriuretic peptide for reduction of restenosis: gene transfer is superior over single peptide administration, J. Gene Med, vol.8, pp.835-879, 2006.

H. Patel, S. Su, C. Patterson, and K. Nguyen, A combined strategy to reduce restenosis for vascular tissue engineering applications, Biotechnol. Prog, vol.22, pp.38-44, 2006.

S. Garg, H. J. Duckers, and P. W. Serruys, Endothelial progenitor cell capture stents: will this technology find its niche in contemporary practice?, Eur. Heart J, vol.31, pp.1032-1037, 2010.

H. Duckers, S. Silber, D. Winter, R. Heijer, P. Rensing et al., Circulating endothelial progenitor cells predict angiographic and intravascular ultrasound outcome following percutaneous coronary interventions in the HEALING-II trial: evaluation of an endothelial progenitor cell capturing stent, EuroIntervention, vol.3, pp.67-75, 2007.

H. Duckers, T. Soullie, P. Den-heijer, B. Rensing, D. Winter et al., Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long term follow-up: final results of the Healing II trial using an endothelial progenitor cell capturing stent (Genous R stent)?. EuroIntervention, vol.3, pp.350-358, 2007.

M. Co, E. Tay, C. Hang, L. Kian, K. Low et al., Use of endothelial progenitor cell capture stent (Genous Bio-Engineered R Stent) during primary percutaneous coronary intervention in acute myocardial infarction: intermediate-to long-term clinical followup, Am. Heart J, vol.155, pp.128-160, 2008.

R. Blindt, F. Vogt, I. Astafieva, C. Fach, M. Hristov et al., A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells, J. Am. Coll. Cardiol, vol.47, pp.1786-95, 2006.

C. Stefanadis, K. Toutouzas, E. Stefanadi, F. Kolodgie, R. Virmani et al., First experimental application of bevacizumab-eluting PC coated stent for inhibition of vasa vasorum of atherosclerotic plaque: angiographic results in a rabbit atheromatic model, Hellenic J. Cardiol, vol.47, pp.7-10, 2006.

G. Nakazawa, J. Granada, C. Alviar, A. Tellez, G. Kaluza et al., Anti-CD34 antibodies immobilized on the surface of sirolimus-eluting stents enhance stent endothelialization, JACC Interventions, vol.3, pp.68-75, 2010.

R. G. Flemming, C. J. Murphy, G. A. Abrams, S. L. Goodman, and P. F. Nealey, Effects of synthetic micro-and nano-structured surfaces on cell behavior, Biomaterials, vol.20, pp.573-88, 1999.

J. Norman and T. Desai, Methods for fabrication of nanoscale topography for tissue engineering scaffolds, Ann. Biomed. Eng, vol.34, pp.89-101, 2006.

A. A. Tseng and A. Notargiacomo, Nanoscale fabrication by nonconventional approaches, J. Nanosci. Nanotechnol, vol.5, pp.683-702, 2005.

A. Dolatshahi-pirouz, M. B. Hovgaard, K. Rechendorff, J. Chevallier, M. Foss et al., Scaling behavior of the surface roughness of platinum films grown by oblique angle deposition, Phys. Rev. B, p.77, 2008.

C. Buzea, G. Beydaghyan, C. Elliott, and R. K. , Control of power law scaling in the growth of silicon nanocolumn pseudo-regular arrays deposited by glancing angle deposition, Nanotechnology, vol.16, pp.1986-92, 2005.

C. N. Lafratta, L. J. Li, and J. T. Fourkas, Soft-lithographic replication of 3D microstructures with closed loops, Proc. Natl. Acad. Sci. U. S. A, vol.103, pp.8589-94, 2006.

A. Pikulin and N. Bityurin, Spatial resolution in polymerization of sample features at nanoscale, Phys. Rev. B, p.75, 2007.

K. Seunarine, D. O. Meredith, M. O. Riehle, C. Wilkinson, and N. Gadegaard, Biodegradable polymer tubes with litho graphically controlled 3D micro-and nanotopography, Microelectron. Eng, vol.85, pp.1350-1354, 2008.

H. J. In, S. Kumar, Y. Shao-horn, and G. Barbastathis, Origami fabrication of nanostructured, three-dimensional devices: Electrochemical capacitors with carbon electrodes, Appl. Phys. Lett, p.88, 2006.

J. C. Palmaz, A. Benson, and E. A. Sprague, Influence of surface topography on endothelialization of intravascular metallic material, J. Vasc. Interv. Radiol, vol.10, pp.439-483, 1999.

C. Fuss, . Se, S. R. Bailey, and J. C. Palmaz, Surface micro grooves (MG) improve endothelialization rate in vitro and in vivo, Am. J. Cardiol, vol.37, issue.2A, p.70, 2001.

J. Lu, M. Rao, N. Macdonald, D. Khang, and T. Webster, Improved endothelial cell adhesion and proliferation on patterned titanium surfaces with rationally designed, micrometer to nanometer features, Acta Biomater, vol.4, pp.192-201, 2008.

A. Ranjan and T. J. Webster, Increased endothelial cell adhesion and elongation on micronpatterned nano-rough poly(dimethylsiloxane) films, Nanotechnology, vol.20, p.305102, 2009.

S. Y. Hwang, K. W. Kwon, K. J. Jang, M. C. Park, J. S. Lee et al., Adhesion Assays of Endothelial Cells on Nanopatterned Surfaces within a Microfluidic Channel, Anal. Chem, vol.82, pp.3016-3038, 2010.

C. Bettinger, Z. Zhang, S. Gerecht, J. T. Borenstein, and R. Langer, Enhancement of in vitro capillary tube formation by substrate nanotopography, Adv. Mater, vol.20, pp.99-103, 2008.

C. Berry, D. Mccloy, and S. Affrossman, Endothelial cell response to narrow diameter nylon tubes exhibiting internal nanotopography, Current Nanoscience, vol.4, pp.219-242, 2008.

S. H. Hsu, C. M. Tang, and C. C. Lin, Biocompatibility of poly(epsiloncaprolactone)/poly(ethylene glycol) diblock copolymers with nanophase separation, Biomaterials, vol.25, pp.5593-601, 2004.

M. J. Dalby, M. O. Riehle, H. Johnstone, S. Affrossman, and A. Curtis, In vitro reaction of endothelial cells to polymer demixed nanotopography, Biomaterials, vol.23, pp.2945-54, 2002.

S. Buttiglieri, D. Pasqui, M. Migliori, H. Johnstone, S. Affrossman et al., Endothelization and adherence of leucocytes to nanostructured surfaces, Biomaterials, vol.24, pp.2731-2739, 2003.

R. Barbucci, D. Pasqui, A. Wirsen, S. Affrossman, A. Curtis et al., Micro and nanostructured surfaces, J. Mater. Sci.-Mater. Med, vol.14, pp.721-726, 2003.

P. Kim, D. H. Kim, B. Kim, S. K. Choi, S. H. Lee et al., Fabrication of nanostructures of polyethylene glycol for applications to protein adsorption and cell adhesion, Nanotechnology, vol.16, pp.2420-2426, 2005.

J. D. Zawislak, K. W. Kolasinski, and B. P. Helmke, Development of endothelial cells on pillarcovered silicon, Physica Status Solidi a-Applications and Materials Science, vol.206, pp.1356-60, 2009.

S. Choudhary, M. Berhe, K. M. Haberstroh, and T. J. Webster, Increased endothelial and vascular smooth muscle cell adhesion on nanostructured titanium and CoCrMo, Int. J. Nanomedicine, vol.1, pp.41-50, 2006.

S. Choudhary, K. M. Haberstroh, and T. J. Webster, Enhanced functions of vascular cells on nanostructured Ti for improved stent applications, Tissue Eng, vol.13, pp.1421-1451, 2007.

D. Khang, J. Lu, C. Yao, K. M. Haberstroh, and T. J. Webster, The role of nanometer and submicron surface features on vascular and bone cell adhesion on titanium, Biomaterials, vol.29, pp.970-83, 2008.

L. Peng, M. L. Eltgroth, T. J. Latempa, C. A. Grimes, and T. A. Desai, The effect of TiO2 nanotubes on endothelial function and smooth muscle proliferation, Biomaterials, vol.30, pp.1268-72, 2009.

H. D. Samaroo, J. Lu, and T. J. Webster, Enhanced endothelial cell density on NiTi surfaces with sub-macron to nanometer roughness, Int. J. Nanomedicine, vol.3, pp.75-82, 2008.

J. Carpenter, D. Khang, and T. J. Webster, Nanometer polymer surface features: the influence on surface energy, protein adsorption and endothelial cell adhesion, Nanotechnology, p.19, 2008.

M. C. Serrano, M. T. Portoles, M. Vallet-regi, I. Izquierdo, L. Galletti et al., Vascular endothelial and smooth muscle cell culture on NaOH-treated poly (epsilon-caprolactone) films: A preliminary study for vascular graft development, Macromol. Biosci, vol.5, pp.415-438, 2005.

D. C. Miller, A. Thapa, K. M. Haberstroh, and T. J. Webster, Endothelial and vascular smooth muscle cell function on poly(lactic-co-glycolic acid) with nano-structured surface features, Biomaterials, vol.25, pp.53-61, 2004.

M. S. Lord, B. G. Cousins, P. J. Doherty, J. M. Whitelock, A. Simmons et al., The effect of silica nanoparticulate coatings on serum protein adsorption and cellular response, Biomaterials, vol.27, pp.4856-62, 2006.

S. Sarkar, M. Dadhania, P. Rourke, T. A. Desai, and J. Y. Wong, Vascular tissue engineering: microtextured scaffold templates to control organization of vascular smooth muscle cells and extracellular matrix, Acta Biomater, vol.1, pp.93-100, 2005.

J. D. Glawe, J. B. Hill, D. K. Mills, and M. J. Mcshane, Influence of channel width on alignment of smooth muscle cells by high-aspect-ratio microfabricated elastomeric cell culture scaffolds, J. Biomed. Mater. Res. Part A, vol.75, pp.106-120, 2005.

G. R. Houtchens, M. D. Foster, T. A. Desai, E. F. Morgan, and J. Y. Wong, Combined effects of microtopography and cyclic strain on vascular smooth muscle cell orientation, J. Biomech, vol.41, pp.762-771, 2008.

E. Yim, R. M. Reano, S. W. Pang, A. F. Yee, C. S. Chen et al., Nanopatterninduced changes in morphology and motility of smooth muscle cells, Biomaterials, vol.26, pp.5405-5418, 2005.

L. Richert, F. Vetrone, J. H. Yi, S. F. Zalzal, J. D. Wuest et al., Surface nanopatterning to control cell growth, Adv. Mater, vol.20, pp.1488-92, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00667267

K. T. Nguyen, K. P. Shukla, M. Moctezuma, and L. P. Tang, Cellular and molecular responses of smooth muscle cells to surface nanotopography, J. Nanosci. Nanotechnol, vol.7, pp.2823-2855, 2007.

J. M. Gao, L. Niklason, and R. Langer, Surface hydrolysis of poly(glycolic acid) meshes increases the seeding density of vascular smooth muscle cells, J. Biomed. Mater. Res, vol.42, pp.417-441, 1998.

A. Thapa, D. C. Miller, T. J. Webster, and K. M. Haberstroh, Nano-structured polymers enhance bladder smooth muscle cell function, Biomaterials, vol.24, pp.2915-2941, 2003.

X. F. Walboomers, H. Croes, L. A. Ginsel, and J. A. Jansen, Growth behavior of fibroblasts on microgrooved polystyrene, Biomaterials, vol.19, pp.1861-1869, 1998.

X. F. Walboomers, H. Croes, L. A. Ginsel, and J. A. Jansen, Contact guidance of rat fibroblasts on various implant materials, J. Biomed. Mater. Res, vol.47, pp.204-216, 1999.

X. F. Walboomers, W. Monaghan, A. Curtis, and J. A. Jansen, Attachment of fibroblasts on smooth and microgrooved polystyrene, J. Biomed. Mater. Res, vol.46, pp.212-232, 1999.

X. F. Walboomers, L. A. Ginsel, and J. A. Jansen, Early spreading events of fibroblasts on microgrooved substrates, J. Biomed. Mater. Res, vol.51, pp.529-563, 2000.

J. Meyle, K. Gultig, and W. Nisch, Variation in contact guidance by human-cells on a microstructured surface, J. Biomed. Mater. Res, vol.29, pp.81-89, 1995.

S. W. Lee, S. Y. Kim, I. C. Rhyu, W. Y. Chung, R. Leesungbok et al., Influence of microgroove dimension on cell behavior of human gingival fibroblasts cultured on titanium substrata, Clin. Oral Implants Res, vol.20, pp.56-66, 2009.

L. S. Chou, J. D. Firth, V. J. Uitto, and D. M. Brunette, Substratum surface-topography alters cell-shape and regulates fribronectin messenger-RNA level, messenger-RNA stability, secretion and assembly in human fibroblasts, J. Cell Sci, vol.108, pp.1563-73, 1995.

S. A. Biela, Y. Su, J. P. Spatz, and R. Kemkemer, Different sensitivity of human endothelial cells, smooth muscle cells and fibroblasts to topography in the nano-micro range, Acta Biomater, vol.5, pp.2460-2466, 2009.

W. A. Loesberg, J. Riet, F. Van-delft, P. Schon, C. G. Figdor et al., The threshold at which substrate nanogroove dimensions may influence fibroblast alignment and adhesion, Biomaterials, vol.28, pp.3944-51, 2007.

F. Sun, D. Casse, J. A. Van-kan, R. W. Ge, and F. Watt, Geometric control of fibroblast growth on proton beam-micromachined scaffolds, Tissue Eng, vol.10, pp.267-72, 2004.

C. C. Berry, M. J. Dalby, D. Mccloy, and S. Affrossman, The fibroblast response to tubes exhibiting internal nanotopography, Biomaterials, vol.26, pp.4985-92, 2005.

M. J. Dalby, M. O. Riehle, H. Johnstone, S. Affrossman, and A. Curtis, Investigating the limits of filopodial sensing: a brief report using SEM to image the interaction between 10 nm high nano-topography and fibroblast filopodia, Cell Biol. Int, vol.28, pp.229-265, 2004.

M. J. Dalby, M. O. Riehle, H. Johnstone, S. Affrossman, and A. Curtis, Nonadhesive nanotopography: Fibroblast response to poly(n-butyl methacrylate)-poly(styrene) demixed surface features, J. Biomed. Mater. Res. Part A, vol.67, pp.1025-1057, 2003.

M. J. Dalby, M. O. Riehle, H. Johnstone, S. Affrossman, and A. Curtis, Polymer-demixed nanotopography: Control of fibroblast spreading and proliferation, Tissue Eng, vol.8, pp.1099-108, 2002.
DOI : 10.1089/107632702320934191

M. J. Dalby, D. Giannaras, M. O. Riehle, N. Gadegaard, S. Affrossman et al., Rapid fibroblast adhesion to 27 nm high polymer demixed nano-topography, Biomaterials, vol.25, pp.77-83, 2004.
DOI : 10.1016/s0142-9612(03)00475-7

M. J. Dalby, N. Gadegaard, M. O. Riehle, C. Wilkinson, and A. Curtis, Investigating filopodia sensing using arrays of defined nano-pits down to 35 nm diameter in size, Int. J. Biochem. Cell Biol, vol.36, pp.2005-2020, 2004.

M. J. Dalby, N. Gadegaard, and C. Wilkinson, The response of fibroblasts to hexagonal nanotopography fabricated by electron beam lithography, J. Biomed. Mater. Res. Part A, vol.84, pp.973-982, 2008.

A. M. Green, J. A. Jansen, J. Vanderwaerden, and A. F. Vonrecum, Fibroblast response to microtextured silicone surfaces: texture orientation into or out of the surface, J. Biomed. Mater. Res, vol.28, pp.647-53, 1994.

K. R. Milner and C. A. Siedlecki, Submicron poly(L-lactic acid) pillars affect fibroblast adhesion and proliferation, J. Biomed. Mater. Res. Part A, vol.82, pp.80-91, 2007.
DOI : 10.1002/jbm.a.31049

K. R. Milner and C. A. Siedlecki, Fibroblast response is enhanced by poly(L-lactic acid) nanotopography edge density and proximity, Int. J. Nanomedicine, vol.2, pp.201-212, 2007.

J. A. Hunt, R. L. Williams, S. M. Tavakoli, and S. T. Riches, Laser surface modification of polymers to improve biocompatibility, J. Mater. Sci.-Mater. Med, vol.6, pp.813-820, 1995.
DOI : 10.1007/bf00134323

M. J. Dalby, C. C. Berry, M. O. Riehle, D. S. Sutherland, H. Agheli et al., Attempted endocytosis of nano-environment produced by colloidal lithography by human fibroblasts, Exp. Cell Res, vol.295, pp.387-94, 2004.

C. H. Choi, S. H. Hagvall, B. M. Wu, J. Dunn, R. E. Beygui et al., Cell interaction with three-dimensional sharp-tip nanotopography, Biomaterials, vol.28, pp.1672-1681, 2007.
DOI : 10.1016/j.biomaterials.2006.11.031

C. H. Choi, S. Heydarkhan-hagvall, B. M. Wu, J. Dunn, R. E. Beygui et al., Cell growth as a sheet on three-dimensional sharp-tip nanostructures, J. Biomed. Mater. Res. Part A, vol.89, pp.804-821, 2009.
DOI : 10.1002/jbm.a.32101

M. J. Dalby, M. O. Riehle, D. S. Sutherland, H. Agheli, and A. Curtis, Use of nanotopography to study mechanotransduction in fibroblasts-methods and perspectives, Eur. J. Cell Biol, vol.83, pp.159-69, 2004.

M. J. Dalby, M. Biggs, N. Gadegaard, G. Kalna, C. Wilkinson et al., Nanotopographical stimulation of mechanotransduction and changes in interphase centromere positioning, J. Cell. Biochem, vol.100, pp.326-364, 2007.

R. J. Vance, D. C. Miller, A. Thapa, K. M. Haberstroh, and T. J. Webster, Decreased fibroblast cell density on chemically degraded poly-lactic-co-glycolic acid, polyurethane, and polycaprolactone, Biomaterials, vol.25, pp.2095-103, 2004.
DOI : 10.1016/j.biomaterials.2003.08.064

B. G. Cousins, P. J. Doherty, R. L. Williams, J. Fink, and M. J. Garvey, The effect of silica nanoparticulate coatings on cellular response, J. Mater. Sci.-Mater. Med, vol.15, pp.355-364, 2004.

M. Dalby, M. Riehle, H. Johnstone, S. Affrossman, and A. Curtis, Polymer-demixed nanotopography: control of fibroblast spreading and proliferation, Tissue Eng, vol.8, pp.1099-108, 2002.